Health Professional Human Clinical Trial Enquiries

Thank you for your interest in EBC-46 (tigilanol tiglate). QBiotics is not able to provide treatment with tigilanol tiglate at this time. Recruitment for the two Phase I/IIA safety studies in Australia and New Zealand is now closed.

QBiotics is currently preparing to undertake a pilot Clinical Phase IIA trial in Australia and India.  Details of this trial will be posted on the company’s website and international clinical trial registries, such as, when we open patient recruitment.